Alzheimer’s disease tau is a prominent pathology in LRRK2 Parkinson’s disease

by Michael X. Henderson, Medha Sengupta, John Q. Trojanowski, Virginia M. Y. Lee
Published 2019-11-01

LRRK2 inhibition does not impart protection from α-synuclein pathology and neuron death in non-transgenic mice

by Michael X. Henderson, Medha Sengupta, Ian McGeary, Bin Zhang, Modupe F. Olufemi, Hannah Brown, John Q. Trojanowski, Virginia M. Y. Lee
Published 2019-02-01